The need for speed

Is the push for faster regulatory approval of new drugs a benefit to patients or a safety risk? The increasing pressure from patients, pharmaceutical companies and sometimes, health professionals, eager to access new medications, needs to be handled cautiously, perhaps via new approval categories, an expert believes.  In an editorial in Australian Prescriber, Paul Kubler,